Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Guardant Health (GH) Asset Writedowns and Impairment (2022 - 2025)

Guardant Health (GH) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with -$5.0 million as the latest value for Q4 2025.

Quarterly Asset Writedowns and Impairment changed N/A to -$5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Sep 2025, changed N/A year-over-year, with the annual reading at $29.1 million for FY2023, 452.25% up from the prior year.
Asset Writedowns and Impairment hit -$5.0 million in Q4 2025 for Guardant Health, down from $5.0 million in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $23.6 million in Q2 2023 to a low of -$5.0 million in Q4 2025.
Historically, Asset Writedowns and Impairment has averaged $6.9 million across 3 years, with a median of $5.3 million in 2022.